Marinus Pharmaceuticals, Inc.

United States of America


 
Total IP 61
Total IP Rank # 22,311
IP Activity Score 2.6/5.0    60
IP Activity Rank # 12,017
Stock Symbol
ISIN US56854Q1013
Market Cap. 15.90M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

28 6
5 3
16 3
0
 
Last Patent 2025 - Amorphous solid dispersion ganax...
First Patent 2005 - Method and system for screening ...
Last Trademark 2023 - SHINING MOMENTS
First Trademark 2020 - ZTALMY

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders. The disclosure ...
Invention Prodrugs of ganaxolone. This disclosure relates to ganaxolone derivatives, as well as methods of...
Invention Ganaxolone for use in treatment of super refractory status epilepticus. This invention relates t...
Invention Amorphous solid dispersion ganaxolone formulation. This disclosure relates to a solid pharmaceut...
Invention Ganaxolone for use in treatment of established status epilepticus. This invention relates to met...
Invention Ganaxolone for use in treating tuberous sclerosis complex. The disclosure to methods for treatin...
Invention Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders. The disclosure t...
2023 Invention Intravenous ganaxolone formulations and methods of use in treating status epilepticus and other s...
Invention Ganaxolone for use in treatment of status epilepticus. This invention relates to methods for tre...
G/S Educational programming series, namely, providing panel discussions, presentation of seminars and...
Invention Use of ganaxolone in treating an epilepsy disorder. The disclosure to methods for treating seizu...
Invention Ganaxolone for use in treating tuberous sclerosis complex. The disclosure to methods for treating...
Invention Prodrugs of ganaxolone. This disclosure relates to ganaxolone derivatives, as well as methods of ...
Invention Injectable neurosteroid formulations containing nanoparticles. The disclosure provides an inject...
2022 Invention Amorphous solid dispersion ganaxolone formulation. This disclosure relates to a solid pharmaceuti...
Invention Ganaxolone for use in treatment of established status epilepticus. This invention relates to meth...
Invention Ganaxolone for use in treatment of status epilepticus. This invention relates to methods for trea...
G/S Pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, epile...
G/S Pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, epil...
Invention Ganaxolone for use in treating genetic epileptic disorders. The disclosure provides a method of ...
G/S Administration of a discount program for enabling participating patients to obtain discounts on c...
2021 Invention Use of ganaxolone in treating an epilepsy disorder. The disclosure to methods for treating seizur...
G/S pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, epile...
Invention Ganaxolone for use in treatment of super refractory status epilepticus. This invention relates to...
G/S Pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, encep...
G/S Pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, ence...
G/S Pharmaceutical preparations for the treatment of epilepsy, epileptic encephalopathies, seizures,...
G/S Pharmaceutical preparations for the treatment of epilepsy, epileptic encephalopathies, seizures, ...
2020 G/S pharmaceutical preparations for the treatment of epilepsy, epileptic encephalopathies, seizures, ...
Invention Methods of treating certain depressive disorders and delirium tremens. The disclosure provides a ...
2019 Invention Ganaxolone for use in prophylaxis and treatment of pospartum depression. Uses of ganaxolone in pr...
Invention Ganaxolone for use in prophylaxis and treatment of postpartum depression. Uses of ganaxolone in p...
2018 Invention Ganaxolone for use in treating genetic epileptic disorders. The disclosure provides a method of t...
Invention Compositions and methods for treating autism spectrum disorder. A method of treating suffering f...
Invention Method of treatment using nanoparticulate ganaxolone formulations. In certain embodiments, the in...
Invention Sustained release injectable neurosteroid formulations. The disclosure provides a sustained relea...
Invention Sustained release injectable neurosteroid formulations. The disclosure provides a sustained rele...
2017 Invention Method of administering a neurosteroid to effect electroencephalographic (eeg) burst suppression....